logo
Select company
Select metric
$ 932KInterest Expense
VS
Market
58
Sector
41
Industry
28
History
93
$ 1.96Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 932K
3/31/2025$ 1.24M
12/31/2024$ 1.37M
6/30/2024$ 1.65M
12/31/2023$ 2.88M
6/30/2023$ 3.75M
12/31/2022$ 4.2M
6/30/2022$ 4.87M
12/31/2021$ 5.03M
6/30/2021$ -111.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Int. Exp. stands at $ 7.98M.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Int. Exp. has been $ -7.06M.
  • The median Int. Exp. for MEREO BIOPHARMA GROUP PLC during this period was $ 2.88M
  • MEREO BIOPHARMA GROUP PLC reached its highest Int. Exp. over the past 5 years at $ 7.98M.
  • The lowest Int. Exp. recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe $ -111.57M

MEREO BIOPHARMA GROUP PLC's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
CRDF : CARDIFF ONCOLOGY INC $ 0ABEO : ABEONA THERAPEUTICS INC $ 4.14MHUMA : HUMACYTE INC $ 10.49MAVTX : AVALO THERAPEUTICS INC $ -2.18MCOYA : COYA THERAPEUTICS INC $ 0ABVC : ABVC BIOPHARMA INC $ 233.56KFDMT : 4D MOLECULAR THERAPEUTICS INC $ 0VTGN : VISTAGEN THERAPEUTICS INC $ 0ERNA : ERNEXA THERAPEUTICS INC $ 5.16MANNX : ANNEXON INC $ 0

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

MREO - Interest Expense, Last 5 years

$ -111.57M

Minimum

Jun 30, 2021

$ 7.98M

Maximum

Dec 31, 2020

$ -7.06M

Average

$ 2.88M

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.75M with a standard deviation of $ 5.5M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.72K
min$ -15.41M
max$ 22.87M
average$ 2.75M
median$ 17K
std$ 5.5M